Biotechnology Innovation Organization– tag –
-
Kincell Bio Strengthens GMP Manufacturing for Autologous & Allogeneic Cell Therapies Across Diverse Modalities from US Two Sites
Kincell Bio USA Overview Kincell Bio announced enhanced GMP manufacturing services for both autologous and allogeneic cell therapy programs, leveraging two advanced facilities in Gainesville, Florida, and Research Triangle Park, North Ca... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ... -
6th iPSC Drug Development Summit to Address GMP Scale-Up Challenges, Focusing on Gene Editing Safety and QC Frameworks
BioInsights International Overview The 6th iPSC Drug Development Summit will primarily focus on challenges associated with scaling iPSC platforms to GMP standards. Key discussions will cover implementing GMP-compatible gene editing strat... -
GEA Expands Biotech Scale-Up with New $4.7M Sarstedt Technology Center for Precision Fermentation & Cell Cultivation
PPTI News Germany Overview GEA has opened a new US$4.7 million biotech Application and Technology Center in Sarstedt, Germany, dedicated to expanding capabilities in precision fermentation, cell cultivation, and industrial process scale-... -
GEA Invests €4M in German Biotech Pilot Centre to Accelerate Precision Fermentation & Cell Cultivation Scale-Up
FoodBev.com Germany Overview GEA has invested €4 million in a new Application and Technology Center (ATC) in Sarstedt, Germany, to accelerate the scale-up of precision fermentation and cell cultivation processes. The center provides pilo... -
Syntax Bio and Applied StemCell Partner to Accelerate Allogeneic Cell Therapies with GMP-Compliant Hypoimmune iPSCs and Cellgorithm Platform
CRISPR Medicine News USA Overview Syntax Bio and Applied StemCell have forged a strategic collaboration to propel next-generation regenerative medicine by advancing stem cell innovation. Applied StemCell will supply GMP-compatible hypoim... -
Syntax Bio & Applied StemCell Partner to Accelerate Allogeneic iPSC Therapies with Low-Immunogenicity Lines and Cellgorithm Platform
Manufacturing Chemist USA Overview Syntax Bio and Applied StemCell have formed a strategic partnership to accelerate programmable iPSC therapy development. This collaboration aims to address key challenges of immune recognition and manuf... -
BioInsights Reports >95% T-Cell Recovery with Closed-Loop Centrifugation, Streamlining Cell Therapy Workflows
BioInsights Global Overview The development of flexible, closed, end-to-end cell therapy manufacturing process workflows is progressing, with the Gibco™ CTS™ Rotea™ Counterflow Centrifugation System demonstrating over 95% primary activat... -
Thermo Fisher Scientific Unveils DynaXS Single-Use Bioreactor and Global Manufacturing Expansion at BIO 2026, Boosting Cell & Gene Therapy Production
Business Wire USA Overview Thermo Fisher Scientific announced significant new manufacturing capabilities and AI-enabled research advancements at BIO International 2026, aiming to strengthen the cell and gene therapy sector. Key highlight... -
Matica Bio Unveils ‘Accelerated Korea IIT Platform’ to Fast-Track Cell & Gene Therapy Development with US-Korea Synergy
PR Newswire South Korea Overview Matica Biotechnology (Matica Bio) has launched its 'Accelerated Matica Korea IIT Integrated Platform Solution,' a strategic initiative in collaboration with South Korean clinical networks to expedite Inve...
